Aggregator
Lefty billionaire’s two-faced response on paying more taxes goes viral
David Stearns still confident his Mets moves despite troubling early results
Eric Swalwell sics private eye on ex-aides as accuser cooperates with Manhattan DA
Mets reveal Francisco Lindor’s injury timeline as Ronny Mauricio looks to seize chance
Cubs star Pete Crow-Armstrong expecting boos at Dodger Stadium
Vladislav Gavrikov’s key development can help Rangers beyond top pair
Trump Administration Seeks Pause Of Lawsuit Challenging Vaccine Recommendations
Authored by Zachary Stieber via The Epoch Times (emphasis ours),
Trump administration lawyers on April 23 said they are still considering whether to appeal a ruling that blocked the rollback of guidance on some vaccines.
Health Secretary Robert Kennedy Jr. on Capitol Hill in Washington on April 22, 2026. Madalina Kilroy/The Epoch TimesThe lawyers said in a filing that pausing the litigation over the guidance pending the resolution of any appeal that is filed would “promote judicial economy and avoid burdens on government agencies that may be rendered unnecessary by a decision on any appeal.”
For instance, if an appeal is filed, the U.S. Court of Appeals for the First Circuit may dismiss some or all of the claims by plaintiffs in the case, which would eliminate the need for the government to produce records sought by plaintiffs, the lawyers told U.S. District Judge Brian Murphy in a motion to stay proceedings pending resolution of any appeal.
“At a minimum, a First Circuit decision on any appeal could narrow the issues in dispute and provide guidance on how to resolve any remaining issues,” the motion stated. “If Defendants continue producing administrative records and the parties start briefing cross-motions for summary judgment before Defendants’ time to appeal has run and before the First Circuit has an opportunity to weigh in on any appeal, there is a significant potential for wasted time and resources.”
Murphy in March stayed the updates made to Centers for Disease Control and Prevention vaccine guidance under Health Secretary Robert F. Kennedy Jr., resulting in the guidance reverting to what had been in place in mid-2025.
Murphy concluded that Kennedy and other officials did not follow proper procedure in updating the guidance and appointing new members to the CDC’s vaccine advisory committee.
That stay would remain in effect even if Murphy approves the requested motion, administration lawyers said.
The lawyers did not say why no appeal has been lodged against Murphy’s decision. They asked him to stay proceedings in the case until whichever comes later: May 15 or the resolution of any appeal the defendants may file.
The deadline to appeal Murphy’s preliminary injunction is May 15.
Shortly after the injunction was issued, the Department of Health and Human Services said it would prevail in an appeal. The department has declined to answer questions about why an appeal has not yet been lodged.
“Unless officially announced by us, any assertions about what we are doing next is baseless speculation,” a department spokesperson told The Epoch Times in March.
The litigation was brought by multiple health care groups, including the American Academy of Pediatrics.
Government lawyers conferred with plaintiffs, who opposed the motion to stay the proceedings.
Tyler Durden Fri, 04/24/2026 - 21:00Tech Now
Dramatic footage shows daring aerial rescue of worker stranded atop towering palm tree
When is deed theft not actually deed theft? It depends says AG Tish James
Mark Ingram uses his son to antagonize the Pittsburgh crowd: ‘Steelers still suck’
FDA Grants Quick Review Psychedelic Drugs, First Approvals Could Come As Soon As Summer
The FDA announced new steps to speed up research on psychedelic treatments for serious mental health conditions, following an executive order from President Donald Trump directing agencies to expand access to emerging therapies, CNBC and NBC reported this morning:
In a press release Friday, FDA commissioner Marty Makary said the medications “have the potential to address the nation’s mental health crisis, including conditions like treatment resistant depression, alcoholism and other serious mental health and substance abuse conditions.” On Monday, Makary told NBC News that with the accelerated application process, the FDA could potentially approve the first psychedelic drug by the end of summer.
The agency said this effort could support new treatments for conditions like treatment-resistant depression, PTSD, and substance use disorders. Measures include prioritizing drugs with early promising results and offering incentives to companies studying compounds such as psilocybin and methylone. It also approved an early clinical trial for noribogaine, marking the first time a drug of its kind will be studied in the U.S.
Officials emphasized that these actions do not mean the treatments are approved or proven safe. All research will be closely monitored to ensure it meets strict scientific and safety standards.
Popular psychedelic names like Compass Pathways and AtaiBeckley have turned positive YTD on on the news out the last few days.
"The executive order I'm signing, we're actually signing the executive order today, is really a moment," Trump said at the signing event days ago. "These treatments are currently in the advanced stages of clinical trials to ensure that they're both safe and effective for the American patients."
Trump's order, signed on Saturday, directs the FDA to prioritize review of certain breakthrough-designated psychedelic therapies, expands potential access under the Right to Try Act, commits at least $50 million in federal funding for state partnerships, and encourages closer coordination among HHS, the FDA, the VA, and private-sector researchers.
"In many cases, these experimental treatments have shown life-changing potential for those suffering from severe mental illness and depression, including our cherished veterans," Trump said, citing the veteran suicide rate.
The order also instructs the Justice Department to move quickly on rescheduling any psychedelic-based product that successfully completes Phase 3 trials and receives FDA approval.
Trump continued, "And the nice part is we're actually doing this early, but it has been going on. Research has been going on for quite some time. But, you know, usually with things like this, nothing ever happens, no matter how the research ends up, but we're changing that. This order will clear away unnecessary bureaucratic hurdles, improve data sharing among the FDA and the Department of Veterans Affairs, and facilitate fast rescheduling of any psychedelic drugs that become FDA-approved."
As we wrote days ago, these stocks are starting to go 'mainstream' after being ignored and out of the limelight for years. Zero Hedge contributor Quoth the Raven has named the sector his “best idea” sector for 2026.
Tyler Durden Fri, 04/24/2026 - 20:30IKEA to open Culver City location — but it won’t be the same blue-box warehouse format
Jets take cornerback D’Angelo Ponds in second round after 2026 NFL Draft pick swap
49ers second-round pick De’Zhaun Stribling is nephew of WWE Hall of Famer Don ‘The Rock’ Muraco
Jets waiting on 2027 NFL Draft for their biggest puzzle piece
Elon Musk and Sam Altman head to court with tough ‘Judge Judy’ firing warning shot at billionaires
Immanuel Quickley out for rest of series against Cavaliers in Raptors injury crusher
A Bottle Of Water Is $4.25: Walt Disney World Might Be The 'Most Expensive On Earth'
Authored by Stephen Silver via 19fortyfive.com,
“Water is $4.50 for a basic Desani. Smartwater is $6.25. Food is almost unaffordable, and people bring their own food now. Soon, we might as well call Walt Disney World here in Florida the Most Expensive Place on Earth.”
That’s what the Editor-In-Chief, Harry J. Kazianis, an avid Disney fan, told me just recently when it came to the Most Magical Place on Earth.
Mickey Mouse Walt Disney World 19FortyFive.com ImageClearly, he isn’t wrong: Disney has announced its ticket price calendar for 2027, and it is raising prices on some tickets, including peak days, according to the new ticket pricing calendar.
Pricing has been announced through October 2027, with pricing for November and December next year yet to be revealed.
Disney World Prices Keep Going Up In FloridaThe ticket pricing scheme at Walt Disney World is dynamic and complex, but, as The Street reported, tickets on some dates will cost more than they did previously.
“While base-level ticket prices remain unchanged, peak-day pricing has quietly climbed, with the most popular dates now reaching up to $219 per day,” The Street reported. “That represents a roughly 10% increase from the previous $199 peak seen in 2025, reinforcing Disney’s continued shift toward demand-based pricing.”
Each of the parks at Walt Disney World in Florida has a price range. Per The Street, The Animal Kingdom has a range of $119 – $189, while EPCOT’s range is $144 – $204. Disney’s Hollywood Studios’ cost ranges from $149 to $209, while the Magic Kingdom Park ranges from $159 to $219.
According to an analysis by MickeyVisit, “we are seeing large increases for single-day tickets, including new peak prices for three theme parks at Walt Disney World.” Disney World, the site says, “uses a dynamic pricing structure, which means single-day ticket costs vary depending on the date, taking into account guest demand, holidays, and other variable factors.”
Epcot in Florida. Image from 19FortyFive.com staff.As that site said, it’s part of an upward trend in Disney pricing.
“Walt Disney World’s prices are continuing to trend upward each time a new set of prices is released,” the MickeyVisit site said. “But if we look at the graph above, we can see that the largest shift is happening at the higher end of pricing. While the lowest 1-day ticket price has only moderately increased over the past decade, the highest-priced tickets have seen a dramatic surge, with prices more than doubling since 2015.”
“Even Disney is Worried”The high cost of the Disney park experience has been a topic of discussion for a long time. Indeed, the Wall Street Journal reported in February of 2025 that rising costs at the parks are a concern that the company itself is aware of. “Even Disney Is Worried About the High Cost of a Disney Vacation” was the Journal’s headline.
It grew out of the pandemic, the Journal reported, when Disney’s parks were closed to the public for over a year, finally returning in April of 2021.
“The Happiest Place on Earth has long felt like one of the most expensive spots on the planet for many Americans—but the allure of a magical family vacation kept visitors streaming in,” the Journal reported.
Walt Disney World Boardwalk Hotel. Image by 19FortyFive.com“Then, as post-pandemic demand soared, Disney put price hikes into overdrive, putting vacations at its theme parks out of reach for many American families. Attendance growth has slowed over the past few years, and even some families that were once regulars are canceling their pilgrimages.”
One-day adult passes to Disneyland, in California, broke the $200 mark for the first time in 2024, the Journal story said.
That story also noted that the rising cost has been questioned inside the company, with surveys of park-goers finding that some were concerned about pricing and considering not returning.
“Some inside Disney worry that the company has become addicted to price hikes and has reached the limits of what middle-class Americans can afford, according to people who have worked on park pricing,” the Journal said. “Internal discussions over whether Disney parks may be losing their grip on the hearts and wallets of families with young kids have become more frequent, some of those people said.”
Disney Annual Passholder August 10, 2023. 19FortyFive.com Image.The Journal also estimated the average cost of a visit.
“For a two-parent family with two young kids, a typical four-day visit to Walt Disney World, including a stay at a value-priced, Disney-owned hotel, costs $4,266 in 2024, according to Touring Plans, a data provider that helps vacationers plan theme park visits. That cost, before food and transportation costs, is up from $3,230 five years earlier, adjusted for inflation,” the newspaper reported.
This happens as the Disney parks business has become a more important part of the Walt Disney Co.’s overall financial picture, which also owns everything from animation studios to Marvel to “Star Wars” to ABC and ESPN. And indeed, Josh D’Amaro, who formerly headed the parks business, earlier this year was named the company’s new CEO, replacing Robert Iger.
What the New Boss ThinksD’Amaro has addressed the issue of rising costs at the Disney parks, including during a March shareholder call, his first as CEO.
The new CEO was asked how the company, under his leadership, will balance shareholder growth with other metrics, such as audience satisfaction, as seen in park prices.
“This is an important question,” the CEO said.
“Our goal is for every single guest to feel that their experience is worth it,” D’Amaro said on that March earnings call. “Basically, we want this experience to be the best day of a guest’s life. And we’re always measuring our success here.”
He also said that guest satisfaction and other metrics are high across Disney’s parks.
Walt Disney World’s Magic Kingdom. Image Credit: 19FortyFive.com“When it comes to how we think about pricing,” the new CEO said. “We focus on offering a wide range of options at different price points so that families can visit in ways that work for them, whether that’s during a value season or taking advantage of multi-day ticket savings or even special offers.”
The previous head of the parks division, who is now taking over as CEO, suggests there’s no major change in pricing strategy for the parks.
“We try to provide a fair amount of choice and flexibility for guests while at the same time making sure that we’re managing daily attendance and the overall guest experience,” D’Amaro said.
Tyler Durden Fri, 04/24/2026 - 20:00